BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers

por Blanchard, Zannel, Paul, Bibbin T, Craft, Barbara, ElShamy, Wael M
Publicado 2015

The pro- and anti-tumor roles of mesenchymal stem cells toward BRCA1-IRIS-overexpressing TNBC cells

por Ryan, Daniel, Paul, Bibbin T., Koziol, Jim, ElShamy, Wael M.
Publicado 2019

Sideroflexin 4 affects Fe-S cluster biogenesis, iron metabolism, mitochondrial respiration and heme biosynthetic enzymes

por Paul, Bibbin T., Tesfay, Lia, Winkler, C. R., Torti, Frank M., Torti, Suzy V.
Publicado 2019

Systems biology of ferroptosis: A modeling approach

por Konstorum, Anna, Tesfay, Lia, Paul, Bibbin T., Torti, Frank M., Laubenbacher, Reinhard C., Torti, Suzy V.
Publicado 2020

Complementary anti-cancer pathways triggered by inhibition of sideroflexin 4 in ovarian cancer

por Tesfay, Lia, Paul, Bibbin T., Hegde, Poornima, Brewer, Molly, Habbani, Samrin, Jellison, Evan, Moore, Timothy, Wu, Hao, Torti, Suzy V., Torti, Frank M.
Publicado 2022

DCYTB is a predictor of outcome in breast cancer that functions via iron-independent mechanisms

por Lemler, David J., Lynch, Miranda L., Tesfay, Lia, Deng, Zhiyong, Paul, Bibbin T., Wang, Xiaohong, Hegde, Poornima, Manz, David H., Torti, Suzy V., Torti, Frank M.
Publicado 2017

BRCA1-IRIS overexpression promotes and maintains the tumor initiating phenotype: implications for triple negative breast cancer early lesions

por Sinha, Abhilasha, Paul, Bibbin T., Sullivan, Lisa M., Sims, Hillary, Bastawisy, Ahmed El, Yousef, Hend F., Zekri, Abdel-Rahman N., Bahnassy, Abeer A., ElShamy, Wael M.
Publicado 2016

Iron addiction: A novel therapeutic target in ovarian cancer

por Basuli, Debargha, Tesfay, Lia, Deng, Zhiyong, Paul, Bibbin, Yamamoto, Yusuke, Ning, Gang, Xian, Wa, McKeon, Frank, Lynch, Miranda, Crum, Christopher P., Hegde, Poornima, Brewer, Molly, Wang, Xiaohong, Miller, Lance D., Dyment, Nathaniel, Torti, Frank M., Torti, Suzy V.
Publicado 2017